Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A group of primary or secondary disorders affecting the muscles. It is characterized by an abnormal reduction in the muscle volume and atrophy. The atrophy may be caused by diseases of the muscle tissues or diseases of the peripheral nerves.
Biomarker and diagnostic research for atrophic muscular disease has been reported in the published literature.
No clinical trials have been registered for atrophic muscular disease.
300 publications have been identified in PubMed for atrophic muscular disease. Research spans Basic Science / Preclinical (56%), Review / Meta-Analysis (22%), and Gene Therapy / Novel Therapeutics (8%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 167 | 56% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 11:55 PM UTC
67 |
22% |
New treatment approaches | 23 | 8% |
Disease patterns and progression | 20 | 7% |
Testing and diagnosis research | 7 | 2% |
Clinical study results | 7 | 2% |
Patient case studies | 6 | 2% |
Other research | 3 | 1% |
Kanazawa G (2026). [PMID: 41443350](https://pubmed.ncbi.nlm.nih.gov/41443350/). *J Control Release*. [Basic Science / Preclinical]
Hindermann M (2026). [PMID: 41729076](https://pubmed.ncbi.nlm.nih.gov/41729076/). *JCI Insight*. [Basic Science / Preclinical]
Gong J (2026). [PMID: 41865897](https://pubmed.ncbi.nlm.nih.gov/41865897/). *Biochem Pharmacol*. [Review / Meta-Analysis]
Menard R (2026). [PMID: 41511973](https://pubmed.ncbi.nlm.nih.gov/41511973/). *PLoS Genet*. [Gene Therapy / Novel Therapeutics]
de Sousa MV (2026). [PMID: 41691131](https://pubmed.ncbi.nlm.nih.gov/41691131/). *Sports Med*. [Review / Meta-Analysis]
Li T (2026). [PMID: 40961381](https://pubmed.ncbi.nlm.nih.gov/40961381/). *Shock*. [Basic Science / Preclinical]
Wang N (2026). [PMID: 40617408](https://pubmed.ncbi.nlm.nih.gov/40617408/). *J Adv Res*. [Review / Meta-Analysis]
Shim W (2026). [PMID: 42091891](https://pubmed.ncbi.nlm.nih.gov/42091891/). *Nat Commun*. [Basic Science / Preclinical]
Counts BR (2026). [PMID: 41722042](https://pubmed.ncbi.nlm.nih.gov/41722042/). *Am J Physiol Cell Physiol*. [Basic Science / Preclinical]
Li C (2026). [PMID: 41529803](https://pubmed.ncbi.nlm.nih.gov/41529803/). *Free Radic Biol Med*. [Epidemiology / Natural History]